These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 8579928
1. A histomorphometric study on effects of single and concurrent intermittent administration of human PTH (1-34) and bisphosphonate cimadronate on tibial metaphysis in ovariectomized rats. Mashiba T, Tanizawa T, Takano Y, Takahashi HE, Mori S, Norimatsu H. Bone; 1995 Oct; 17(4 Suppl):273S-278S. PubMed ID: 8579928 [Abstract] [Full Text] [Related]
2. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats. Takano Y, Tanizawa T, Mashiba T, Endo N, Nishida S, Takahashi HE. J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340 [Abstract] [Full Text] [Related]
3. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia. Shen V, Dempster DW, Mellish RW, Birchman R, Horbert W, Lindsay R. Calcif Tissue Int; 1992 Mar; 50(3):214-20. PubMed ID: 1617495 [Abstract] [Full Text] [Related]
4. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. Qi H, Li M, Wronski TJ. J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319 [Abstract] [Full Text] [Related]
5. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L. J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862 [Abstract] [Full Text] [Related]
6. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats. Iwaniec UT, Moore K, Rivera MF, Myers SE, Vanegas SM, Wronski TJ. Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182 [Abstract] [Full Text] [Related]
7. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB. Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618 [Abstract] [Full Text] [Related]
8. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Wronski TJ, Yen CF, Qi H, Dann LM. Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497 [Abstract] [Full Text] [Related]
9. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Baumann BD, Wronski TJ. Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054 [Abstract] [Full Text] [Related]
10. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats. Lane NE, Thompson JM, Strewler GJ, Kinney JH. J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502 [Abstract] [Full Text] [Related]
11. Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats. Li M, Wronski TJ. Bone; 1995 May; 16(5):551-7. PubMed ID: 7544601 [Abstract] [Full Text] [Related]
12. Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats. Zhang L, Endo N, Yamamoto N, Tanizawa T, Takahashi HE. Tohoku J Exp Med; 1998 Oct; 186(2):131-41. PubMed ID: 10223616 [Abstract] [Full Text] [Related]
13. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats. Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR. Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456 [Abstract] [Full Text] [Related]
14. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model. Mosekilde L, Danielsen CC, Søgaard CH, McOsker JE, Wronski TJ. Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051 [Abstract] [Full Text] [Related]
15. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat. Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA. Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756 [Abstract] [Full Text] [Related]
18. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Li M, Mosekilde L, Søgaard CH, Thomsen JS, Wronski TJ. Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439 [Abstract] [Full Text] [Related]
19. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. Li M, Liang H, Shen Y, Wronski TJ. Bone; 1999 Feb; 24(2):95-100. PubMed ID: 9951776 [Abstract] [Full Text] [Related]
20. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ. J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]